In order to preserve function in glaucoma, it is necessary -but not sufficient -to keep RGC bodies alive in the retina. Maintenance of visual function requires preservation of all compartments of the RGC including the axon, dendrites and distal synapses. 8 Only if all components of the cell survive and continue to function can vision be preserved. However, it is becoming clear that the therapeutic strategies required to protect different compartments may differ. As an example, RGC bodies in the retina are known to die by apoptosis, 9
which is an active cell death programme that involves a cascade of events that lead to the orderly demise of a cell. In transgenic mice with hereditary glaucoma that also lack Bax, a major component of the apoptotic pathway, RGC loss from the retina is greatly reduced, but axonal degeneration continues. 10 Thus, blocking apoptosis is insufficient to prevent RGC axonal degeneration in glaucoma, and therapeutic strategies to protect axons are potentially worth exploring for their ability to alleviate glaucoma progression.
Axoprotection
In order to protect axons it is necessary to understand the mechanisms by which they degenerate. Axonal degeneration can occur by several mechanisms, but Wallerian degeneration frequently occurs, especially following major axonal injury. Wallerian degeneration is an active process that leads to the orderly breakdown of axons in response to injury, and mutations that block this process can enhance axonal survival. 
Problems with Detecting Progression in Glaucoma
In addition to helping us understand the mechanisms underlying degeneration of RGC in glaucoma, basic science research is playing an important role in the search for new ways to measure progression. Other approaches to the measurement of progression in current clinical use include assessment of the nerve fibre layer and the 3D structure of the optic nerve head using scanning laser ophthalmoscopy, ocular coherence tomography and polarimetry.
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These techniques can provide evidence of structural changes associated with glaucoma progression, but are relatively insensitive to small changes. Thus, new techniques with the ability to rapidly determine with precision the exact rate of glaucomatous progression would be a major advance.
Using Basic Science to Improve Detection of Progression
Detailed understanding of the mechanisms of RGC loss in glaucoma has the potential to suggest new approaches to the assessment of progression. As an example, the observation that RGC death in glaucoma occurs by apoptosis means that existing techniques to visualise apoptosing cells may be applied to the glaucomatous eye. Additional challenges will be introduced if the apoptosis rate in glaucoma subjects and controls is not uniform, with cell death
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